NCT03537690View on ClinicalTrials.gov

FID-007 in Treating Participants With Advanced Solid Tumors

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 25, 2018

Primary Completion Date

May 25, 2026

Study Completion Date

May 25, 2027

Conditions
Advanced Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

DRUG

PEOX-based Polymer Encapsulated Paclitaxel FID-007

Given IV

OTHER

Pharmacokinetic Study

Correlative studies

Trial Locations (3)

90033

Los Angeles General Medical Center, Los Angeles

USC / Norris Comprehensive Cancer Center, Los Angeles

92663

Hoag Memorial Hospital, Newport Beach

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Southern California

OTHER